AtriCure Inc (ATRC) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
AtriCure, Inc.
Total Cash From Operating Activities Chart for AtriCure Inc
AtriCure Inc (ATRC) operating cash flow for FY2025 was USD 57.3M, a 369.8% change from FY2024. AtriCure Inc's operating cash flow moved from USD -3.8M in 2004 to USD 57.3M in 2025 over 21 years.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $2.85B
- Implied Share Price
- $56.07
- Enterprise Value
- $2.95B
- Revenue (TTM)
- $569.62M
- EBITDA
- $33.75M
- Profit Margin
- 1.85%
- Trailing P/E
- 267.00
- Forward P/E
- 232.56
- Price/Book (MRQ)
- 5.79
- Price/Sales (TTM)
- 5.01
- EV/EBITDA
- 75.06
- EV/Revenue
- 5.08
- Dividend Yield
- —
- Book Value
- $10.15
- Free Cash Flow (FY2025)
- $48.28M
- Free Cash Flow Yield
- 1.69%
Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.